Prevention of Future Deaths reports · 2026

Roger Smith

Regulation 28 report to prevent future deaths, reference 2026-0069, written 6 Feb 2026. A coroner writes one of these when an inquest reveals a risk that could cause further deaths unless something changes.

Date of report6 Feb 2026
Reference2026-0069
DeceasedRoger Smith
CoronerDarren Stewart
Coroner areaSuffolk
CategoryHospital Death (Clinical Procedures and medical management) related deaths
Organisation namedWest Suffolk NHS Foundation Trust
Sourcejudiciary.uk record · original PDF
Responses published1

The report

Text extracted from the PDF text layer. Reproduced verbatim, including the scan's own layout.

REGULATION 28: REPORT TO PREVENT FUTURE DEATHS

NOTE: This form is to be used after an inquest.

REGULATION 28 REPORT TO PREVENT FUTURE DEATHS

THIS REPORT IS BEING SENT TO:

1

, Chief Executive Officer, West Suffolk Hospital NHS

Foundation Trust

1

CORONER

I am Darren STEWART OBE, HM Area Coroner for the coroner area of Suffolk

2

CORONER’S LEGAL POWERS

I make this report under paragraph 7, Schedule 5, of the Coroners and Justice Act 2009
and Regulations 28 and 29 of the Coroners (Investigations) Regulations 2013.

3

INVESTIGATION and INQUEST

On 03 October 2023 I commenced an investigation into the death of Roger Knight SMITH
aged 80.

The investigation concluded at the end of the inquest on 29 January 2026.

The conclusion of the inquest was:

Narrative Conclusion - Roger Knight SMITH was a much loved and desperately
missed member of his Family. He was a man who had a great zest for life,
described by his family as amazing, exceptionally intelligent, creative, kind,
adventurous and funny. A person who during his life had a significant, positive
impact on the lives of those around him.

Mr. SMITH’s previous medical history included a diagnosis of cerebral amyloid
angiopathy (CAA) following a stroke in 2012. He suffered a further stroke in 2016
which resulted in hospitalisation and from which he made a good recovery.

Due to his diagnosis of and treatment for cerebral amyloid angiopathy, Mr. SMITH
suffered from an increased risk of suffering from strokes. As a consequence, Mr.
SMITH presented as a patient with complex considerations for his clinical care and
management.

Mr Smith was admitted to West Suffolk Hospital on 14th April 2023 with confusion,
hallucinations and generalised weakness. He was treated with antibiotics for a
clinical differential diagnosis of infection of uncertain origin. On 28th April he was
commenced on steroids for a possible alternative diagnosis of vasculitis. On 1st
May he developed slurred speech. A computed tomography (CT) head scan
showed new multiple left intracerebral haemorrhages. He was subsequently
transferred to the stroke unit where he received treatment in relation to his
stroke. He subsequently developed a Clostridium Difficile (C Diff) infection and
received treatment in relation to this.

The speed of Mr. SMITH’s recovery was adversely affected by the fact that he was
unable to engage effectively with the physiotherapy treatment offered. This was
because of the inappropriate prescription and administration of baclofen over the
period 27th June to the 24th July 2023. Mr. SMITH was discharged on the 21st

Regulation 28 – After Inquest
Document Template Updated 30/07/2021

 August 2023 having been assessed as medically fit for discharge.

Mr Smith was readmitted to West Suffolk Hospital on 25th August 2023 with
increased bowel motion frequency and drowsiness. A diagnosis of recurrent C. Diff
infection was made and treatment for this condition commenced. He was also
commenced on low dose tinzaparin for venous thromboembolism (VTE)
prophylaxis on the 26th August 2023.

Correspondence from treating neurologists at another hospital that formed part of
Mr. SMITH’s medical records and which advised against the prescription of anti-
coagulation therapy was not followed. Mr. SMITH declined tinzaparin
administration on the 27th and 28th August 2023. This did not prompt a discussion
between clinicians and either Mr. SMITH or his family as to the reason why he had
declined. Nor were alternative forms of management of the VTE risk discussed as
had been the case during the 14th April to 21st August 2023 West Suffolk Hospital
admission. Seven further doses of tinzaparin were administered to Mr. SMITH
over the period 29th August to the 4th September 2023.

On 4th September 2023 Mr. SMITH developed a fever, tachycardia, tachypnoea and
reduced consciousness level. He was treated for aspiration pneumonia and sepsis.
A CT head scan on 5th September 2023 showed a new large right cerebral
haemorrhage with interventricular extension. A repeat CT head scan on 7th
September 2023 showed an increase in the haemorrhage size and mass effect
with midline shift. A palliative care referral was made. Treatment with antibiotics
for pneumonia and C Diff. continued. Sadly Mr SMITH deteriorated further and
died on 12th September 2023.

A postmortem examination of Mr. SMITH’s body established that his medical
cause of death was due to Bronchopneumonia arising from immobility due to the
effects of the stroke he had suffered on the 4th September 2023.

Roger Knight SMITH died due to the effects of suffering a stroke brought about by
the administration of tinzaparin over the period 21st August – 4th September 2023.

The medical cause of death was confirmed as:

1a Bilateral Bronchopneumonia
1b Immobility
1c Recurring Intracranial Haemorrhages

2 Cerebral Amyloid Angiopathy, Hypertension, Clostridium Difficile Infection and
Coronary Arteries Atherosclerosis

4

CIRCUMSTANCES OF THE DEATH

Narrative Conclusion see part 4.

5

CORONER’S CONCERNS

During the course of the inquest the evidence revealed matters giving rise to concern. In
my opinion there is a risk that future deaths could occur unless action is taken. In the
circumstances it is my statutory duty to report to you.

The MATTERS OF CONCERN are as follows:

Important information relating to advice concerning the prescription of
anti-coagulation therapy (low weight molecular heparin - LWMH) for
venous thromboembolism (VTE) prophylaxis and which was contained in
Mr. Smith’s medical records, was not flagged for clinican attention as part
of the electronic records management system in use at West Suffolk

Regulation 28 – After Inquest
Document Template Updated 30/07/2021

 Hospital. This meant that when Mr. Smith was readmitted on the 25th
August 2023, this information did not form part of the reviewing
consultants considerations around whether to precribe tinzaparin (LWMH)
to Mr. Smith for VTE prophalaxis. He subsequently recived 8 doses of
tinzaparin which contributed to him suffering a catastrophic stroke that led
to his death.

During both admissions to West Suffolk Hospital during the period April to
August 2023, Mr. Smith and his Family fiercely advocated for
considerations associated with his cerebral amyloid angiopathy (CAA) to
be taken into account as part of his care and treatment. This occurred
during Mr. Smith’s first admission between 14th April and 21st August 2023
with alternative management used to address the VTE risk. This did not
occur during Mr. Smith’s second admission from 25th August 2023 and
despite Mr. Smith declining tinzaparin on two occasions, the medication
continued to be administered without adequate consideration as to why
Mr. Smith had declined it or by engaging in consultation with either Mr.
Smith or his Family.

There was limited input from the West Suffolk Hospital stroke team into
Mr. Smith’s care and treatment during the period following his admission
on the 14th April 2023 until his stroke on the 1st May 2023. This was
notwithstanding Mr. Smith and his Family raising on multiple occasions the
increased risk of stroke to Mr. Smith due to his pre-existing CAA condition.
Following his stroke on the 1st May 2023, measures taken to diagnose the
stroke, move Mr. Smith to a stroke unit and correctly manage his blood
pressure in accordance with NICE guidelines were slow, and with respect
to blood pressure management, non-concordant with existing national
stroke guidance.

I am concerned that the West Suffolk Hospital patient records
management system is ineffective in accurately highlighting important
information which should inform patient care and treatment.

I am concerned that communication processes at West Suffolk Hospital
between patients and hospital staff (including treating clinicians) are
ineffective in affording patients and their families with adequate
opportunity to engage with and inform clinical decisions around their care
and treatment.

I am concerned that effective procedures are not in place at West Suffolk
Hospital to deliver timely specialist stroke team input for the purposes of
managing stroke risk as part of a multi-disciplinary team approach for
patients admitted with conditions that expose them to higher risk of VTE
(e.g. CAA).

6

ACTION SHOULD BE TAKEN

In my opinion action should be taken to prevent future deaths and I believe you (and/or
your organisation) have the power to take such action.

7

YOUR RESPONSE

You are under a duty to respond to this report within 56 days of the date of this report,
namely by April 3rd, 2026. I, the coroner, may extend the period.

Your response must contain details of action taken or proposed to be taken, setting out the
timetable for action. Otherwise you must explain why no action is proposed.

8

COPIES and PUBLICATION

Regulation 28 – After Inquest
Document Template Updated 30/07/2021

 I have sent a copy of my report to the Chief Coroner and to the following Interested
Persons

The Family of Roger Knight Smith

I have also sent it to

The Care Quality Commission

who may find it useful or of interest.

I am also under a duty to send a copy of your response to the Chief Coroner and all
interested persons who in my opinion should receive it.  

I may also send a copy of your response to any other person who I believe may find it
useful or of interest.

The Chief Coroner may publish either or both in a complete or redacted or summary form.
He may send a copy of this report to any person who he believes may find it useful or of
interest.

You may make representations to me, the coroner, at the time of your response, about the
release or the publication of your response.

9

Dated: 06/02/2026

Darren STEWART OBE
HM Area Coroner for
Suffolk

Regulation 28 – After Inquest
Document Template Updated 30/07/2021

Responses

1 response published against this report on judiciary.uk. A response is a body's written reply to the coroner's concerns; publication is at the discretion of the Chief Coroner's office, so an absent response does not mean nobody replied.

Response from West Suffolk NHS Foundation Trust (PDF)
West Suffolk NHS Foundation Trust
Hardwick Lane
Bury St Edmunds
Suffolk
IP33 2QZ

31 March 2026 

Mr Darren Stewart, OBE 
HM Area Coroner for Suffolk 
Ipswich Coroner’s Court 
Beacon House 
Whitehouse Road 
Ipswich 
Suffolk 
IP1 5PB 

Dear Mr Stewart 

WSFT information relating to Regulation 28 Report into the death of Roger Smith 

I write further to the report dated 6 February 2026, issued following your inquest into the death of Roger 
Smith.    West  Suffolk  NHS  Foundation  Trust  (WSFT)  acknowledges  HM  Coroner’s  concerns  and  is 
grateful for the opportunity to outline the actions taken. 

In advance of responding to the specific concerns raised in your Report, we would like to express our 
deep condolences to Mr Smith’s family. WSFT are keen to assure Mr Smith’s family that the concerns 
raised have been listened to, reviewed and reflected upon.   

Please find below details of the ongoing work to address your three concerns, which we hope is of some 
small comfort to Mr Smith’s family and friends. 

Coroner’s Concern 1 - I am concerned that the West Suffolk Hospital patient records management 
system is ineffective in accurately highlighting important information which should inform patient care 
and treatment. 

This concern has been reviewed by the Digital and Medicine teams to explore if it is possible to create 
a  digital  solution  for  this  issue  and to  consider  the  process  of  adding  alerts  to  the  electronic  patient 
record system, known locally as eCare. Unfortunately, based on current system capabilities, it is not 
possible to create an automated digital alert within eCare to warn prescribers against anticoagulating 
patients with cerebral amyloid angiopathy (CAA).  

that  eCare  does  not  support  a  universal 
The  Digital  and  Medicines 
contraindication‑based alerting function (a digital pop up).  Instead, alerts must be built in manually for 
every individual drug. This would require bespoke configuration for each anticoagulant (of which there 
are many). It is also not possible to group drugs together by class to raise a generic alert either. As a 
result, it is not possible to manage a digital alert system at scale. 

teams  confirm 

Furthermore, CAA is not listed as a contraindication for tinzaparin in the BNF (British National Formulary 
– which is a comprehensive resource for healthcare professionals, featuring recommended guidance 
on prescribing, dispensing, and administering medications), meaning there is no nationally recognised 
evidence  base  on  which  to  construct  a “hard‑stop”  alert.   Implementing  such  an  alert  for  CAA  alone 
would set a false expectation that the system can flag all clinical contraindications across all medicines, 
which  is  neither  possible  nor  safe,  as  prescribing  decisions  require  a  clinician’s  judgement  and  a 
patient‑specific risk–benefit assessment. When exploring what was possible the Digital team found that 

    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 deciding to prescribe anticoagulants involves a complex decision model requiring the weighing up of a 
number  of factors to balance the risk  and benefit  specifically  relevant  in CAA.  These  considerations 
cannot  be  reliably  reduced  to  automated  rules  without  generating  significant  alert  fatigue  or 
inappropriate overrides. For these reasons, any adjustment of practice needs to occur through clinical 
pathways (e.g., updating VTE assessment guidance) rather than through an electronic prescribing alert.  

After  exploring  the  Digital  option  and  ruling  this  out  for  the  reasons  above,  in  order  to  address  your 
concern, WSFT intends to take the following action: - 

•  WSFT will take forward a clinically‑led change to strengthen the visibility of risk factors within 

the existing VTE assessment processes.  

As the current eCare system cannot technically support contraindication‑based alerting across 
all medications without creating new patient‑safety risks, the Trust will instead work through the 
Thrombosis Committee to consider adding an explicit reference within the VTE assessment tool 
to  prompt  clinicians  to  review  “chronic  conditions  that  may  increase  the  bleeding  risk  (e.g., 
CAA).”  This  ensures  CAA  is  considered  during  VTE  prophylaxis  decision‑making  while 
remaining consistent with national guidance and system constraints. This clinical‑governance 
route will allow any agreed change to be embedded into Trust guidelines. 

•  The Trust will also strengthen the clarity of nursing roles and responsibilities in recognising and 
escalating risks associated with patients who repeatedly refuse medication. Whilst refusals of 
medication  are  documented  by  nursing  staff  within  the  electronic  drug  chart,  this  information 
does not always reach the prescribing team. To address this gap, the Trust will work with senior 
nursing  leadership  to  reinforce  expectations  around  proactive  escalation,  particularly  where 
medication  is  repeatedly  refused,  or  where  a  patient  or  family  expresses  concerns  about 
treatment risk. This will include reviewing existing nursing handover processes, ensuring nurses 
understand when and how to raise medication‑related concerns directly with the medical team, 
and identifying opportunities to embed this into local nursing practice guidance. These steps will 
complement the  technical  and clinical  governance actions  already  underway and  ensure  that 
the  nursing  contribution  to  safe  VTE‑prophylaxis  decision‑making  is  clearly  defined  and 
consistently applied. 

•  There  is  also  a  Quality  Improvement  Project  (QIP)  on  ‘safer  handovers’  currently  underway. 
Although  this  project  is  looking  to  improve  the  reported  safety  and  effectiveness  of  nurse-to-
nurse  transfers  between  adult  inpatient  wards,  part  of  this  involves  looking  at  how  essential 
information  is  highlighted.  It  is  hoped  this  project  will  improve  the  quality  of  records  which  is 
accessible to all healthcare teams and drive-up standards.  

We will continue to monitor the effect of these changes outlined above and whether any further steps 
are necessary to promote the safe prescribing of medication.  

Coroner’s  Concern  2  -  I  am  concerned  that  communication  processes  at  West  Suffolk  Hospital 
between patients and hospital staff (including treating clinicians) are ineffective in affording patients and 
their families with adequate opportunity to engage with and inform clinical decisions around their care 
and treatment. 

Since  Mr  Smith’s  death on  12  September  2023, the  Trust  has  adopted  the  national  Call 4 Concern / 
Martha’s  Rule  programme.  As  part  of  this  initiative,  it  introduces  a  daily  structured  patient‑wellness 
question, enabling both doctors and nurses to engage proactively with patients regarding their condition 
and any emerging concerns. 

The  programme  provides  a  standardised  response  matrix  that  supports  staff  to  escalate  concerns 
consistently  and  ensures  patients  and  families  are  afforded  regular  opportunities  to  contribute  to 
decisions  about  their  care.  After  a  successful  pilot  on  wards  F7  and G4,  demonstrating  measurable 
improvement in patient–staff communication and early identification of deterioration, Martha’s Rule/Call 

 
 
 
 
 
 
 
 
 
 
 
 for Concern, was implemented at West Suffolk Hospital on 1 May 2024 across all inpatient areas. This 
initiative  provides  patients,  relatives,  carers  and  staff  with  a  direct  route  to  request  an  independent 
clinical review if they are worried about a patient’s clinical deterioration and feel their concerns have not 
been  adequately  addressed  by  the  ward  team.    Between  May  2024  and  February  2026,  the  team 
received 255 calls. 73 calls were related to clinical deterioration (29%).  

The Critical Care Outreach Team (CCOT) is responsible for delivering this service. Their responsibilities 
include: 

•  Receiving all calls. 
•  Conducting an initial triage to assess the nature and urgency of the concern. 
•  Attending the relevant ward/inpatient area to speak with the individuals raising the concern. 
•  Liaising with the ward team to review the situation collaboratively and ensure appropriate clinical 

action is taken. 

•  Referrals to different specialities, including intensive care if deemed necessary. 
• 
If required, organising/facilitating multidisciplinary teams (MDT) meetings. 

This process aims to strengthen patient safety, support open communication and provides an additional 
safeguard for patients experiencing clinical deterioration.  I am sorry that it was not in place at the time 
of Mr Smith’s care. 

Coroner’s  Concern  3  -  I  am  concerned  that  effective  procedures  are  not  in  place  at  West  Suffolk 
Hospital to deliver timely specialist stroke team input for the purposes of managing stroke risk as part 
of a multi-disciplinary team approach for patients admitted with conditions that expose them to higher 
risk of VTE (e.g. CAA). 

Another quality improvement project the Trust has focused on is working to standardise board rounds 
and  huddles  to  ensure:  consistent  MDT  (multi-disciplinary  team)  presence;  structured  information 
sharing; and, constructive challenge across medical ward areas. Through the PDSA (Plan, Do, Study, 
Act)  cycles,  the  Trust  has  now  implemented  a  standardised  process  across  general  medical  wards, 
recognising the importance of consistent MDT engagement in supporting safe and effective patient care. 

Further  review  work  is  underway  with  the  project  team  to  continually  assess  whether  the  project  is 
achieving its aim and to refine the approach further where needed. Ongoing monitoring will continue to 
support improvement and help ensure that any improvements made are sustained. 

In addition, medical teams have been reminded that the Early Stroke Outreach Team service is available 
24/7 to provide support with referrals, including guidance on pathway requirements and assistance with 
completing the necessary documentation with targeted internal communications.  

To provide some additional assurance about the Trust’s ability to deliver timely specialist stroke team 
input,  the  Trust  has  been  awarded  an  A  rating  by  the  Sentinel  Stroke  National  Audit  Programme 
(SSNAP) for the past six years.  In our last audit, WSFT scored 94 out of 100.  SSNAP audit spans the 
whole journey and measures how well stroke care is being delivered.  

for  bringing this important  patient  safety 

Thank  you 
this 
information assists to address your concerns and please do not hesitate to contact us should you need 
any further information.  

to our attention. We  hope 

issue 

Yours sincerely, 

Chief Executive Officer

Related reports

Other reports by Darren Stewart

See all →

More reports categorised “Hospital Death (Clinical Procedures and medical management) related deaths”

See all →

Track West Suffolk NHS Foundation Trust

See every Prevention of Future Deaths report matching West Suffolk NHS Foundation Trust, and how often a new one appears.

What would an alert for this have sent me? Search the full text

Free to try — the preview shows the real matches and how many arrived in the last 12 months. Your first email alert is free.

These reports are published by the Chief Coroner's office at judiciary.uk and are © Crown copyright. The text here is reproduced from the published PDF so it can be searched. If something on this page is wrong, or you are a person named in it and want it reviewed, email drcjar@gmail.com and we will act promptly.